• 2008 Archive
• 2007 Archive
• 2006 Archive
• 2005 Archive
• 2004 Archive
  • Trevisan named dean of SPHHP
  • A light in the dark
  • Higher levels of marker for liver toxicity found in African Americans
  • Carotid Artery Thickening, Stiffness Found in Obese Children as Young as seven
  • Study finds expanding waistline may bring fatty liver disease
  • Weight Gain Increases Cancer Risk
  • $1 Million Grant will Support Innovative Worksite Wellness Programs
  • A Benefit of Soy
  • Furthering Assistive Technology
  • Colonoscopies advised
  • Textbooks for blind students "come alive"
  • Moderate-Fat Diet is Kinder to Heart than Low-Fat Diet
• 2003 Archive

Colonoscopies advised

March 25, 2004

Get a routine colonoscopy, whether or not you are taking hormone therapy after menopause.

That's the primary message women should take away from the latest study from the Women's Health Initiative (WHI) on the relationship of estrogen and progestin replacement and colon cancer, said study co-author and UB researcher Jean Wactawski-Wende.

Results of the study, which appeared in the March 4 issue of The New England Journal of Medicine, showed that while there were fewer colon cancers among women in the treatment group than among women taking a placebo, colon cancers that did develop in the treatment group were more advanced when diagnosed, suggesting a poorer outcome.

Wactawski-Wende, second author on the study, co-directs UB's WHI Vanguard Center and is an assistant professor of social and preventive medicine and gynecology and obstetrics.

Go to Full Article